prof. MUDr. Michael Doubek, Ph.D.
Head of the research group, Michael Doubek Research Group: Genetic predisposition to hematologic disorders Neuroscience
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Phone: | +420 532 23 2144, 3603 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 866
2016
-
Monoallelic TP53 abnormalities in CLL: do they really exist? The frequency and clinical impact of copy-neutral loss of heterozygosity
Year: 2016, type: Conference abstract
-
Mutations in SF3B1 gene are selected independently on ATM/TP53 status and reduce the time to first treatment in CLL patients.
Year: 2016, type: Conference abstract
-
Nová kombinace antigenů vhodná pro sledování minimální reziduální nemoci u vlasatobuněčné leukemie metodou průtokové cytometrie.
Year: 2016, type: Conference abstract
-
Pro-apoptotic effects of prima-1met correlate with Noxa gene induction in chronic lymphocytic leukemia cells
Year: 2016, type: Conference abstract
-
Prognostic Significance of Surfactant Protein A, Surfactant Protein D, Clara Cell Protein 16, S100 Protein, Trefoil Factor 3, and Prostatic Secretory Protein 94 in Idiopathic Pulmonary Fibrosis, Sarcoidosis, and Chronic Pulmonary Obstructive Disease
Sarcoidosis Vasculitis and Diffuse Lung Diseases, year: 2016, volume: 33, edition: 3
-
Příprava linií rezistentních k působení anti-CD20 monoklonálních protilátek a analýza signálních drah u B-lymfoidních malignit
Year: 2016, type: Conference abstract
-
Raritní nálezy z laboratoře průtokové cytometrie
Year: 2016, type: Conference abstract
-
Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab–containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial
The Lancet Haematology, year: 2016, volume: 3, edition: 7, DOI
-
Rituximab preferentially eliminates BCR signaling proficient chronic lymphocytic leukemia B cells In Vivo
Year: 2016, type: Conference abstract
-
ROR1-based immunomagnetic protocol allows efficient separation of CLL and healthy B cells
British Journal of Haematology, year: 2016, volume: 175, edition: 2, DOI